PRESS RELEASE
News
-
-
-
PRESS RELEASE
Transaction Update
Arix Bioscience PLC (ARIX) announces the recommended all-share acquisition of its assets by RTW Biotech Opportunities Ltd. The timetable for the scheme remains as set out in the shareholder circular, with the second general meeting to be held on 12 February 2024 in London, United Kingdom -
-
PRESS RELEASE
Holding(s) in Company
Arix Bioscience PLC (ARIX) has announced that Acacia Research Corporation, through its subsidiary Merton Acquisition Holdco LLC, has crossed the threshold of voting rights in the company. This notification is in accordance with the TR-1 standard form for notification of major holdings. -
PRESS RELEASE
Holding(s) in Company
Arix Bioscience PLC (ARIX) has received a notification of major holdings from RTW Investments, LP, and RTW Biotech Opportunities Operating Ltd, indicating an increase to a 25.52% stake in the company. The notification was received on 17/01/2024 and comprises 33,023,210 voting rights. -
PRESS RELEASE
Update on the Scheme and Resignation of Directors
Arix Bioscience PLC provides an update on the recommended all-share acquisition of Arix's assets by RTW Biotech Opportunities Ltd, including the resignation of directors Maureen O'Connell and Isaac Kohlberg. The Scheme's condition related to the Share Purchase has been satisfied, and Arix expects to publish the Shareholder circular later this week. -
-
PRESS RELEASE
PDMR Notification & Director Shareholding
-
PRESS RELEASE
Unaudited NAV for October 2023
